Clinical Trials Browser

Phase 4 × Autoimmune Diseases × telitacicept × Clear all

NCT06723548 2024-12-09

Telitacicept and Low-dose Steroids in Refractory Myasthenia Gravis

Phase 4 Not yet recruiting

Autoimmune Diseases, Myasthenia Gravis